The throat pastilles and cough drops market share is expected to increase to USD 1.11 billion from 2021 to 2026, and the market's growth momentum will accelerate at a CAGR of 3.61%.
This throat pastilles and cough drops market research report provides valuable insights on the post COVID-19 impact on the market, which will help companies evaluate their business approaches. Furthermore, this report extensively covers throat pastilles and cough drops market segmentation by type (hard tablet lozenges, soft tablet lozenges, and compressed tablet lozenges) and geography (North America, Europe, Asia, and Rest of World (ROW)). The throat pastilles and cough drops market report also offers information on several market vendors, including Blackmores Ltd., Dr. Willmar Schwabe India Pvt. Ltd., Ernest Jackson & Co. Ltd, GlaxoSmithKline Plc, iNova Pharmaceuticals, Island Abbey Foods Ltd., Johnson and Johnson, Pfizer Inc., Prestige Consumer Healthcare Inc., Reckitt Benckiser Group PLC, Ricola Ltd., Sanofi SA, The Procter and Gamble Co., Belmora LLC, DISCH AG, Bliss GVS Pharma Ltd., Boyd Pharmaceuticals, Cipla Health Ltd., Lozys Pharmaceuticals SL, Thornton and Ross Ltd., and STADA Arzneimittel AG among others.
What will the Throat Pastilles and Cough Drops Market Size be During the Forecast Period?

Download the Free Report Sample to Unlock the Throat Pastilles and Cough Drops Market Size for the Forecast Period and Other Important Statistics
Throat Pastilles and Cough Drops Market: Key Drivers, Trends, and Challenges
Based on our research output, there has been a neutral impact on the market growth during and post COVID-19 era. The advantages over other dosage forms is notably driving the throat pastilles and cough drops market growth, although factors such as side effects and challenges associated with excipients may impede the market growth. Our research analysts have studied the historical data and deduced the key market drivers and the COVID-19 pandemic impact on the throat pastilles and cough drops industry. The holistic analysis of the drivers will help in deducing end goals and refining marketing strategies to gain a competitive edge.
Key Throat Pastilles and Cough Drops Market Driver
One of the key factors driving growth in the throat pastilles and cough drops market is the advantages over other dosage forms. Oral dosage forms are economical, safe, and the easiest route of drug administration. Similarly, their toxicity (if any) is delayed due to the delayed onset of action, which permits easier recovery than that in the case of other dosage forms. In the case of other dosage forms such as parenteral, there are several requirements for the administration of drugs, such as the requirement of aseptic techniques in the production, compounding, and handling of the product, as well as the requirement of trained personnel for administration followed by psychological pain associated with the injection. Owing to the advantages of oral dosage forms, throat pastilles and cough drops are highly preferred by patients. Currently, several types of lozenges available in the market are capable of providing several health benefits and relief from symptoms of diseases. As a result, patient propensity toward the easily available dosage forms of lozenges has increased, thereby driving the market growth.
Key Throat Pastilles and Cough Drops Market Trend
The emergence of innovative products is a throat pastilles and cough drops market trend that is expected to have a positive impact in the coming years. Specific characteristics of modernization, such as rapid air transit, have enhanced the emergence as well as the spread of viruses globally. There has been an increase in the prevalence of various diseases, such as pneumonia, influenza, and various other respiratory diseases, caused by different pathogens. The most common symptoms of these diseases are cough, sore throat, and pain, which can get worse if not treated and can cause other serious diseases. Therefore, the rising prevalence of these diseases has led to the emergence of innovative products that can treat or give relief from multiple symptoms in one dosage. For instance, Catalent Inc. (Catalent) has developed a dual-action lozenge for the delivery of multiple active ingredients for immediate and long-lasting benefits. This innovative product has several advantages, such as the ability to combine water-soluble and fat-soluble active pharmaceutical ingredients, the ability to handle a high local concentration of active pharmaceutical ingredients, and a dissolvable shell that offers a prolonged release profile. Therefore, the emergence of innovative products is a positive trend for the market.
Key Throat Pastilles and Cough Drops Market Challenge
The side effects and challenges associated with excipients will be a major challenge for the throat pastilles and cough drops market during the forecast period. Excipients are ingredients that are added to lozenges for enhancing the flavor and dissolving the drug. Also, some excipients are added to enhance the quality of the product and to help make the medicine more acceptable to users. However, the use of excipients is associated with several challenges. Therefore, the addition of excipients to lozenges can deter patients from taking medicine. Also, certain excipients, such as tartrazine, amaranth, and cochineal red, can cause allergic reactions in patients. Similarly, excipients are also responsible for several adverse drug reactions. In children, these excipients have been reported to have adverse reactions such as lactic acidosis, lactose intolerance, and headache. Therefore, such side effects and challenges associated with the use of excipients might increase the buyer's propensity to shift toward substitutes, thereby posing a challenge to the market growth.
This throat pastilles and cough drops market analysis report also provides detailed information on other upcoming trends and challenges that will have a far-reaching effect on the market growth. The actionable insights on the trends and challenges will help companies evaluate and develop growth strategies for 2022-2026.
Parent Market Analysis
Technavio categorizes the global throat pastilles and cough drops market as a part of the global pharmaceuticals market within the overall healthcare industry. Our research report has extensively covered external factors influencing the parent market growth potential in the coming years, which will determine the levels of growth of the throat pastilles and cough drops market during the forecast period.
Who are the Major Throat Pastilles and Cough Drops Market Vendors?
The report analyzes the market's competitive landscape and offers information on several market vendors, including:
- Blackmores Ltd.
- Dr. Willmar Schwabe India Pvt. Ltd.
- Ernest Jackson & Co. Ltd
- GlaxoSmithKline Plc
- iNova Pharmaceuticals
- Island Abbey Foods Ltd.
- Johnson and Johnson
- Pfizer Inc.
- Prestige Consumer Healthcare Inc.
- Reckitt Benckiser Group PLC
- Ricola Ltd.
- Sanofi SA
- The Procter and Gamble Co.
- Belmora LLC
- DISCH AG
- Bliss GVS Pharma Ltd.
- Boyd Pharmaceuticals
- Cipla Health Ltd.
- Lozys Pharmaceuticals SL
- Thornton and Ross Ltd.
- STADA Arzneimittel AG
This statistical study of the throat pastilles and cough drops market encompasses successful business strategies deployed by the key vendors. The throat pastilles and cough drops market is fragmented and the vendors are deploying growth strategies such as focusing on enhancing their distribution channels to compete in the market.
Product Insights and News
-
blackmores.com.au - The company offers non melanoma skin cancer that includes aldara imiquimod cream to treat superficial basal cell carcinoma, a form of non-melanoma skin cancer.
-
blackmores.com.au - The safety and industrial segment focuses on industrial abrasives and finishing for metalworking applications, autobody repair solutions, closure systems for personal hygiene products, masking, and packaging materials.
To make the most of the opportunities and recover from post COVID-19 impact, market vendors should focus more on the growth prospects in the fast-growing segments, while maintaining their positions in the slow-growing segments.
The throat pastilles and cough drops market forecast report offers in-depth insights into key vendor profiles. The profiles include information on the production, sustainability, and prospects of the leading companies.
Throat Pastilles and Cough Drops Market Value Chain Analysis
Our report provides extensive information on the value chain analysis for the throat pastilles and cough drops market, which vendors can leverage to gain a competitive advantage during the forecast period. The end-to-end understanding of the value chain is essential in profit margin optimization and evaluation of business strategies. The data available in our value chain analysis segment can help vendors drive costs and enhance customer services during the forecast period.
Which are the Key Regions for Throat Pastilles and Cough Drops Market?

For more insights on the market share of various regions Request for a FREE sample now!
34% of the market's growth will originate from North America during the forecast period. US and Canada are the key markets for throat pastilles and cough drops in North America. Market growth in this region will be faster than the growth of the market in the European and ROW regions.
The increasing incidence of cough and colds and other diseases, including influenza and pneumonia, causing symptoms such as coughing and sore throat.will facilitate the throat pastilles and cough drops market growth in North America over the forecast period. This market research report entails detailed information on the competitive intelligence, marketing gaps, and regional opportunities in store for vendors, which will assist in creating efficient business plans.
COVID Impact and Recovery Analysis
Due to COVID-19, most pharmaceutical companies focused on developing vaccines and manufacturing drugs to support the medical crisis related to COVID-19. Due to this, the production volume of drugs, including throat pastilles and cough drops, decreased in this region. However, in 2021, the initiation of large-scale vaccination drives led to the lifting of lockdown and travel restrictions, which led to the resumption of manufacturing and supply chain activities in this region, including the market in focus.
What are the Revenue-generating Type Segments in the Throat Pastilles and Cough Drops Market?

To gain further insights on the market contribution of various segments Request for a FREE sample
The throat pastilles and cough drops market share growth by the hard tablet lozenges segment will be significant during the forecast period. The availability of these lozenges with multiple actions has resulted in their increased use globally. In addition, the availability of these lozenges in multiple colors and flavors, such as blackcurrant, cherry, honey, and lemon, has increased their acceptance and popularity among people.
This report provides an accurate prediction of the contribution of all the segments to the growth of the throat pastilles and cough drops market size and actionable market insights on post COVID-19 impact on each segment.
Throat Pastilles and Cough Drops Market Scope
|
Report Coverage
|
Details
|
Page number
|
120
|
Base year
|
2021
|
Forecast period
|
2022-2026
|
Growth momentum & CAGR
|
Accelerate at a CAGR of 3.61%
|
Market growth 2022-2026
|
$ 1.11 billion
|
Market structure
|
Fragmented
|
YoY growth (%)
|
3.21
|
Regional analysis
|
North America, Europe, Asia, and Rest of World (ROW)
|
Performing market contribution
|
North America at 34%
|
Key consumer countries
|
US, Canada, Mexico, Germany, UK, and Japan
|
Competitive landscape
|
Leading companies, Competitive strategies, Consumer engagement scope
|
Key companies profiled
|
Blackmores Ltd., Dr. Willmar Schwabe India Pvt. Ltd., Ernest Jackson & Co. Ltd, GlaxoSmithKline Plc, iNova Pharmaceuticals, Island Abbey Foods Ltd., Johnson and Johnson, Pfizer Inc., Prestige Consumer Healthcare Inc., Reckitt Benckiser Group PLC, Ricola Ltd., Sanofi SA, The Procter and Gamble Co., Belmora LLC, DISCH AG, Bliss GVS Pharma Ltd., Boyd Pharmaceuticals, Cipla Health Ltd., Lozys Pharmaceuticals SL, Thornton and Ross Ltd., and STADA Arzneimittel AG
|
Market dynamics
|
Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID 19 impact and recovery analysis and future consumer dynamics, Market condition analysis for the forecast period
|
Customization purview
|
If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized.
|
Request for a FREE sample
What are the Key Data Covered in this Throat Pastilles and Cough Drops Market Report?
- CAGR of the market during the forecast period 2022-2026
- Detailed information on factors that will drive throat pastilles and cough drops market growth during the next five years
- Precise estimation of the throat pastilles and cough drops market size and its contribution to the parent market
- Accurate predictions on upcoming trends and changes in consumer behavior
- The growth of the throat pastilles and cough drops industry across North America, Europe, Asia, and Rest of World (ROW)
- A thorough analysis of the market's competitive landscape and detailed information on vendors
- Comprehensive details of factors that will challenge the growth of throat pastilles and cough drops market vendors
We can help! Our analysts can customize this report to meet your requirements. Get in touch